Anti-Human HER2 (Pertuzumab Biosimilar)
Catalog #500048
| Cat # | Size | Price | Quantity | |
|---|---|---|---|---|
| 500048 | 1 mg | $200.00 | ||
| 500048 | 5 mg | $600.00 | ||
| 500048 | 20 mg | $1,250.00 |
Product Details
Pertuzumab biosimilar is a humanized monoclonal antibody targeting HER2 (ErbB-2), designed to inhibit HER2 dimerization and signaling, thereby reducing tumor growth. It is used primarily in cancer research and therapeutic applications.
Specifications
| Clone | Pertuzumab |
|---|---|
| Reactivities | Human |
| Isotype | Human IgG1 |
| Recommended Isotype Control | Human IgG1 isotype control |
| Format | Liquid |
| Formluation | PBS, pH 7.4 |
| Sterility | 0.2 µm filtered |
| Clonality | Recombinant |
| Conjugation | Unconjugated |
| Immunogen | Human ErbB-2 / Her2 |
| Host | CHO cells |
| Purity | >95% (HPLC, SDS-PAGE) |
| Endotoxin | < 1.0 EU/mg (LAL assay) |
| Grade | In vivo ready (RUO) |
| Application | Neutralization; Flow Cytometry; ELISA; WB |
| Purification | Protein A |
| Storage Conditions | 2-8 °C, Avoid freeze / thaw cycle |
| Shelf Life | 6 months |
| Regulatory Status | RUO |